The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection

The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interven...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anna L McNaughton, Philippa C Matthews, Caitlin M Pley, José Lourenço
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine (General) R5-920 Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/7e24a7fe4abc470a8ca07b0677e07d4c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7e24a7fe4abc470a8ca07b0677e07d4c
record_format	dspace
spelling	oai:doaj.org-article:7e24a7fe4abc470a8ca07b0677e07d4c2021-11-20T07:30:05ZThe global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection10.1136/bmjgh-2020-0042752059-7908https://doaj.org/article/7e24a7fe4abc470a8ca07b0677e07d4c2021-01-01T00:00:00Zhttps://gh.bmj.com/content/6/1/e004275.fullhttps://doaj.org/toc/2059-7908The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interventions on economic and public health inequalities, as well as on pre-existing programmes targeting endemic pathogens. We provide an overview of the impact of the ongoing COVID-19 pandemic on hepatitis B virus (HBV) programmes globally, focusing on the possible consequences for prevention, diagnosis and treatment. Ongoing disruptions to infrastructure, supply chains, services and interventions for HBV are likely to contribute disproportionately to the short-term incidence of chronic hepatitis B, providing a long-term source of onward transmission to future generations that threatens progress towards the 2030 elimination goals.Anna L McNaughtonPhilippa C MatthewsCaitlin M PleyJosé LourençoBMJ Publishing GrouparticleMedicine (General)R5-920Infectious and parasitic diseasesRC109-216ENBMJ Global Health, Vol 6, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920 Infectious and parasitic diseases RC109-216
spellingShingle	Medicine (General) R5-920 Infectious and parasitic diseases RC109-216 Anna L McNaughton Philippa C Matthews Caitlin M Pley José Lourenço The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
description	The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interventions on economic and public health inequalities, as well as on pre-existing programmes targeting endemic pathogens. We provide an overview of the impact of the ongoing COVID-19 pandemic on hepatitis B virus (HBV) programmes globally, focusing on the possible consequences for prevention, diagnosis and treatment. Ongoing disruptions to infrastructure, supply chains, services and interventions for HBV are likely to contribute disproportionately to the short-term incidence of chronic hepatitis B, providing a long-term source of onward transmission to future generations that threatens progress towards the 2030 elimination goals.
format	article
author	Anna L McNaughton Philippa C Matthews Caitlin M Pley José Lourenço
author_facet	Anna L McNaughton Philippa C Matthews Caitlin M Pley José Lourenço
author_sort	Anna L McNaughton
title	The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
title_short	The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
title_full	The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
title_fullStr	The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
title_full_unstemmed	The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
title_sort	global impact of the covid-19 pandemic on the prevention, diagnosis and treatment of hepatitis b virus (hbv) infection
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/7e24a7fe4abc470a8ca07b0677e07d4c
work_keys_str_mv	AT annalmcnaughton theglobalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT philippacmatthews theglobalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT caitlinmpley theglobalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT joselourenco theglobalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT annalmcnaughton globalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT philippacmatthews globalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT caitlinmpley globalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection AT joselourenco globalimpactofthecovid19pandemiconthepreventiondiagnosisandtreatmentofhepatitisbvirushbvinfection
_version_	1718419491175530496

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection

Ejemplares similares